View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Terminating coverage

ABGSC terminates coverage of Cary Group HOLD is our final recommendation SEK 70 is our final target price

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Offer raised to SEK 70 – down to HOLD

Teniralc raises offer to SEK 70 (65), board recommends While still a bit low, we think the deal will likely go through Down to HOLD (Buy), lower TP to SEK 70 (90)

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Good Q2, Board out with opinion on bid

Strong Q2 driven by M&A and Nordic margins We leave our estimates roughly unchanged Board recommends long-term investors not to accept bid

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Strong Q2 beats expectations by 3-7%

Adj. EBITA 3-7% better after adj. for earn-out effect Good cash flow, ND/EBITDA of 4.3x to decline from here No news on ongoing SEK 65 bid by Nordic Capital/CVC

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Entering high season

Q2 report due on 12 August Earnings stepping up in Q2 on seasonality and M&A Maintain BUY, adjusting TP to SEK 90 (100)

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Nordic Capital and CVC bid SEK 65 per share

Bid of SEK 65 – a 60% premium vs. yesterday’s close Multiples at SEK 65 roughly in line with peers We find the bid too low, doesn’t capture long-term values

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Margins to improve from Q2 onwards

Small Q1 miss, operational improvement ahead We lower ’22e-‘23e adj. EBITA by 1-2% Maintain BUY, lower TP to SEK 100 (115)

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Slightly lower margins hold back EBITA

Q1’22 adj. EBITA -6% vs. ABGSCe and consensus We see ‘22e adj. EBITA down by 1-3% Maintain BUY, conference call at 10.00 CET

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Strong earnings growth coming in ’22e

Lower-than-expected EBITA, mainly on Group costs Growth offsets margins, ests. roughly unchanged Keep BUY and SEK 115 TP, we see upside of >50%

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Strong sales, group costs held back EBITA

Adj. EBITA 36m vs. ABGSCe SEK 44m in small Q4 Good organic growth at 8% vs. ABGSCe 4% We see limited earnings revisions, keep BUY

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Acquisition potential proven in Q4

Q4’21 report due 11 February Estimates raised after acquisition spree Maintain BUY, raise TP to SEK 115 (110)

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Solid Q3, M&A pace set to increase

Q3’21 EBITA 15% ahead of ABGSCe Strengthened M&A pipeline, higher deal pace coming up Upgrade to BUY with SEK 110 (108) target price

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Weaker org growth, strong EBITA

Q3’21 EBITA SEK 82m +15% vs. ABGSCe Org decline of 2% on difficult comps (ABGSCe +6%) Strong margins bode well for the future

Adrian Gilani ... (+2)
  • Adrian Gilani
  • Olof Cederholm

Cary Group - Thinner glass, stronger growth

High growth in non-cyclical markets Sales and EBITA CAGRs of 15% and 21% in ’20-’25e Initiate coverage with HOLD and SEK 108 target price

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch